Vincent Mase, MD, BS
Assistant Professor of Surgery (Thoracic)
Research & Publications
Biography
News
Locations
Coauthors
Selected Publications
- So Now We Know – Reflections on the Extent of Resection for Stage I Lung CancerDetterbeck F, Ely S, Udelsman B, Blasberg J, Boffa D, Dhanasopon A, Mase V, Woodard G. So Now We Know – Reflections on the Extent of Resection for Stage I Lung Cancer. Clinical Lung Cancer 2023 PMID: 38310034, DOI: 10.1016/j.cllc.2023.12.007.
- Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care NetworkUdelsman B, Detterbeck F, Tanoue L, Mase V, Boffa D, Blasberg J, Dhanasopon A, Ely S, Mazzarelli L, Bader A, Woodard G. Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network. Journal Of Computer Assisted Tomography 2023, 48: 222-225. PMID: 37832536, DOI: 10.1097/rct.0000000000001549.
- Brief Report: Increasing Prevalence of Ground-Glass Nodules and Semisolid Lung Lesions on Outpatient Chest Computed Tomography ScansWoodard G, Udelsman B, Prince S, Blasberg J, Dhanasopon A, Gange C, Traube L, Mase V, Boffa D, Detterbeck F, Bader A. Brief Report: Increasing Prevalence of Ground-Glass Nodules and Semisolid Lung Lesions on Outpatient Chest Computed Tomography Scans. JTO Clinical And Research Reports 2023, 4: 100583. PMID: 38074773, PMCID: PMC10709040, DOI: 10.1016/j.jtocrr.2023.100583.
- Overall survival in low-comorbidity patients with stage I non–small cell lung cancer who chose stereotactic body radiotherapy compared to surgeryUdelsman B, Canavan M, Zhan P, Ely S, Park H, Boffa D, Mase V. Overall survival in low-comorbidity patients with stage I non–small cell lung cancer who chose stereotactic body radiotherapy compared to surgery. Journal Of Thoracic And Cardiovascular Surgery 2023, 167: 822-833.e7. PMID: 37500052, DOI: 10.1016/j.jtcvs.2023.07.021.
- PP01.12 Increasing Diagnosis of Ground Glass Nodules and Semi-Solid Lung Lesions on Chest CT Scans over the Past DecadeWoodard G, Tanoue L, Detterbeck F, Boffa D, Mase V, Blasberg J, Dhanasopon A, Gosangi B, Traube L, Bader A. PP01.12 Increasing Diagnosis of Ground Glass Nodules and Semi-Solid Lung Lesions on Chest CT Scans over the Past Decade. Journal Of Thoracic Oncology 2023, 18: e15. DOI: 10.1016/j.jtho.2022.09.038.
- The evidence behind lung cancer screening: a narrative review of randomized clinical trialsMase V, Kumbasar U, Detterbeck F. The evidence behind lung cancer screening: a narrative review of randomized clinical trials. Current Challenges In Thoracic Surgery 2023, 0: 0-0. DOI: 10.21037/ccts-21-30.
- Surgical Management of Pneumothorax and Pleural Space DiseaseDhanasopon AP, Blasberg JD, Mase VJ. Surgical Management of Pneumothorax and Pleural Space Disease. Surgical Clinics Of North America 2022, 102: 413-427. PMID: 35671764, DOI: 10.1016/j.suc.2022.03.001.
- Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the USErmer T, Canavan ME, Maduka RC, Li AX, Salazar MC, Kaminski MF, Pichert MD, Zhan PL, Mase V, Kluger H, Boffa DJ. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US. JAMA Network Open 2022, 5: e2219535. PMID: 35771575, PMCID: PMC9247736, DOI: 10.1001/jamanetworkopen.2022.19535.
- A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumorsBade BC, Blasberg JD, Mase VJ, Kumbasar U, Li AX, Park HS, Decker RH, Madoff DC, Brandt WS, Woodard GA, Detterbeck FC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813753, PMCID: PMC9264070, DOI: 10.21037/jtd-21-1825.
- A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablationPark HS, Detterbeck FC, Madoff DC, Bade BC, Kumbasar U, Mase VJ, Li AX, Blasberg JD, Woodard GA, Brandt WS, Decker RH. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablation. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813762, PMCID: PMC9264060, DOI: 10.21037/jtd-21-1826.
- A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patientsDetterbeck FC, Mase VJ, Li AX, Kumbasar U, Bade BC, Park HS, Decker RH, Madoff DC, Woodard GA, Brandt WS, Blasberg JD. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patients. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813747, PMCID: PMC9264068, DOI: 10.21037/jtd-21-1824.
- A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation— part 1: a guide to decision-makingDetterbeck FC, Blasberg JD, Woodard GA, Decker RH, Kumbasar U, Park HS, Mase VJ, Bade BC, Li AX, Brandt WS, Madoff DC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation— part 1: a guide to decision-making. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813719, PMCID: PMC9264102, DOI: 10.21037/jtd-21-1823.
- Revisiting Indications for Brain Imaging During the Clinical Staging Evaluation of Lung CancerPichert MD, Canavan ME, Maduka RC, Li AX, Ermer T, Zhan PL, Kaminski M, Udelsman BV, Blasberg JD, Mase VJ, Dhanasopon AP, Boffa DJ. Revisiting Indications for Brain Imaging During the Clinical Staging Evaluation of Lung Cancer. JTO Clinical And Research Reports 2022, 3: 100318. PMID: 35540711, PMCID: PMC9079298, DOI: 10.1016/j.jtocrr.2022.100318.
- Comparing a Novel Hand-Held Device for Chest Tube Insertion to the Traditional Open Tube Thoracostomy for Simple Pneumothorax in a Porcine Model.Dilday J, Heidenreich B, Spitzer H, Abuhakmeh Y, Ahnfeldt E, Watt J, Mase V. Comparing a Novel Hand-Held Device for Chest Tube Insertion to the Traditional Open Tube Thoracostomy for Simple Pneumothorax in a Porcine Model. Journal Of Special Operations Medicine 2022, 22: 41-45. PMID: 36525010, DOI: 10.55460/sh55-ifp6.
- Formal Military Civilian Affiliations Are a Template for Low Military Cardiothoracic Surgery VolumeDeBarros M, Jaklitsch M, Bueno R, Mase VJ. Formal Military Civilian Affiliations Are a Template for Low Military Cardiothoracic Surgery Volume. The Annals Of Thoracic Surgery 2021, 114: 621-624. PMID: 34597685, DOI: 10.1016/j.athoracsur.2021.08.055.
- Can the Centers for Medicare and Medicaid Star Ratings Be Used as a Realistic Approach to Reduce Mortality in Complex Cancer Surgery?Papageorge M, Hoag J, Resio B, Monsalve A, Pathak R, Mase V, Dhanasopon A, Blasberg J, Boffa D. Can the Centers for Medicare and Medicaid Star Ratings Be Used as a Realistic Approach to Reduce Mortality in Complex Cancer Surgery? Journal Of The American College Of Surgeons 2019, 229: s144. DOI: 10.1016/j.jamcollsurg.2019.08.319.
- Quality of Thoracic Lymph Node Evaluation in the Department of Defense According to the American College of Surgeons Commission on Cancer Surveillance Measure: Is There a Survival Benefit?Heidenreich B, Durkee A, Bader J, Ahnfeldt E, Mase V. Quality of Thoracic Lymph Node Evaluation in the Department of Defense According to the American College of Surgeons Commission on Cancer Surveillance Measure: Is There a Survival Benefit? Journal Of The American College Of Surgeons 2018, 227: s185. DOI: 10.1016/j.jamcollsurg.2018.07.395.
- Admission physiology criteria upon presentation to combat support hospitals; are current critical vital signs effective?Mase V, Baer D, Wade C, Eastridge B, Walters T. Admission physiology criteria upon presentation to combat support hospitals; are current critical vital signs effective? Journal Of The American College Of Surgeons 2010, 211: s106. DOI: 10.1016/j.jamcollsurg.2010.06.280.
- Effect of skeletal muscle ischemia‐reperfusion (I/R) postconditioning (Post C) on antioxidant status in ratsDubick M, Mase V, Barr J, Grubbs D, Roe J, Walters T. Effect of skeletal muscle ischemia‐reperfusion (I/R) postconditioning (Post C) on antioxidant status in rats. The FASEB Journal 2010, 24: 591.3-591.3. DOI: 10.1096/fasebj.24.1_supplement.591.3.